No answer from my chemist friend yet, but I did find this.
Benzaldehyde is noticibly *absent* from this list:
--glen
o / cut along this line
--X----------------------------------------------------------------------------
o \
http://www.iarc.fr/monoeval/crthall.htm
Overall Evaluations of Carcinogenicity to Humans
As evaluated in IARC Monographs Volumes 1-69 (a total of 836 agents,
mixtures and exposures)
----------------------------------------------------------------------------
This list contains all hazards evaluated to date, according to the type of
hazard posed and to the type of exposure. Where appropriate, chemical
abstract numbers are given [in square brackets]. For details of the
evaluation, the relevant Monograph should be consulted (volume number given
in round brackets, followed by year of publication of latest evaluation).
Use a free-text search to find a particular compound.
----------------------------------------------------------------------------
Group 1: Carcinogenic to humans (74)
Agents and groups of agents
Aflatoxins, naturally occurring [1402-68-2] (Vol. 56; 1993)
4-Aminobiphenyl [92-67-1] (Vol. 1, Suppl. 7; 1987)
Arsenic [7440-38-2] and arsenic compounds (Vol. 23, Suppl. 7; 1987)
(NB: This evaluation applies to the group of compounds as a whole and not
necessarily to all individual compounds within the group)
Asbestos [1332-21-4] (Vol. 14, Suppl. 7; 1987)
Azathioprine [446-86-6] (Vol. 26, Suppl. 7; 1987)
Benzene [71-43-2] (Vol. 29, Suppl. 7; 1987)
Benzidine [92-87-5] (Vol. 29, Suppl. 7; 1987)
Beryllium [7440-41-7] and beryllium compounds (Vol. 58; 1993)
(NB: Evaluated as a group)
N,N-Bis(2-chloroethyl)-2-naphthylamine (Chlornaphazine) [494-03-1] (Vol. 4,
Suppl. 7; 1987)
Bis(chloromethyl)ether [542-88-1] and chloromethyl methyl ether [107-30-2]
(technical-grade) (Vol. 4, Suppl. 7; 1987)
1,4-Butanediol dimethanesulfonate (Busulphan; Myleran) [55-98-1] (Vol. 4,
Suppl. 7; 1987)
Cadmium [7440-43-9] and cadmium compounds (Vol. 58; 1993)
(NB: Evaluated as a group)
Chlorambucil [305-03-3] (Vol. 26, Suppl. 7; 1987)
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU;
Semustine) [13909-09-6] (Suppl. 7; 1987)
Chromium[VI] compounds (Vol. 49; 1990)
(NB: Evaluated as a group)
Ciclosporin [79217-60-0] (Vol. 50; 1990)
Cyclophosphamide [50-18-0] [6055-19-2] (Vol. 26, Suppl. 7; 1987)
Diethylstilboestrol [56-53-1] (Vol. 21, Suppl. 7; 1987)
Erionite [66733-21-9] (Vol. 42, Suppl. 7; 1987)
Ethylene oxide [75-21-8] (Vol. 60; 1994)
(NB: Overall evaluation upgraded from 2A to 1 with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Helicobacter pylori (infection with) (Vol. 61; 1994)
Hepatitis B virus (chronic infection with) (Vol. 59; 1994)
Hepatitis C virus (chronic infection with) (Vol. 59; 1994)
Human immunodeficiency virus type 1 (infection with) (Vol. 67; 1996)
Human papillomavirus type 16 (Vol. 64; 1995)
Human papillomavirus type 18 (Vol. 64; 1995)
Human T-cell lymphotropic virus type I (Vol. 67; 1996)
Melphalan [148-82-3] (Vol. 9, Suppl. 7; 1987)
8-Methoxypsoralen (Methoxsalen) [298-81-7] plus ultraviolet A radiation
(Vol. 24, Suppl. 7; 1987)
MOPP and other combined chemotherapy including alkylating agents (Suppl. 7;
1987)
Mustard gas (Sulfur mustard) [505-60-2] (Vol. 9, Suppl. 7; 1987)
2-Naphthylamine [91-59-8] (Vol. 4, Suppl. 7; 1987)
Nickel compounds (Vol. 49; 1990)
(NB: Evaluated as a group)
Oestrogen replacement therapy (Suppl. 7; 1987)
Oestrogens, nonsteroidal (Suppl. 7; 1987)
(NB: This evaluation applies to the group of compounds as a whole and not
necessarily to all individual compounds within the group)
Oestrogens, steroidal (Suppl. 7; 1987)
(NB: This evaluation applies to the group of compounds as a whole and not
necessarily to all individual compounds within the group)
Opisthorchis viverrini (infection with) (Vol. 61; 1994)
Oral contraceptives, combined (Suppl. 7; 1987)
(NB: There is also conclusive evidence that these agents have a protective
effect aginst cancers of the ovary and endometrium)
Oral contraceptives, sequential (Suppl. 7; 1987)
Radon [10043-92-2] and its decay products (Vol. 43; 1988)
Schistosoma haematobium (infection with) (Vol. 61; 1994)
Silica [14808-60-7], crystalline (inhaled in the form of quartz or
cristobalite from occupational sources) (Vol. 68; 1997)
Solar radiation (Vol. 55; 1992)
Talc containing asbestiform fibres (Vol. 42, Suppl. 7; 1987)
Tamoxifen [10540-29-1] (Vol. 66; 1996)
(NB: There is also conclusive evidence that this agent (tamoxifen) reduces
the risk of contralateral breast cancer)
2,3,7,8-Tetrachlorodibenzo-para-dioxin [1746-01-6] (Vol. 69; 1997)
(NB: Overall evaluation upgraded from 2A to 1 with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Thiotepa [52-24-4] (Vol. 50; 1990)
Treosulfan [299-75-2] (Vol. 26, Suppl. 7; 1987)
Vinyl chloride [75-01-4] (Vol. 19, Suppl. 7; 1987)
Mixtures
Alcoholic beverages (Vol. 44; 1988)
Analgesic mixtures containing phenacetin (Suppl. 7; 1987)
Betel quid with tobacco (Vol. 37, Suppl. 7; 1987)
Coal-tar pitches [65996-93-2] (Vol. 35, Suppl. 7; 1987)
Coal-tars [8007-45-2] (Vol. 35, Suppl. 7; 1987)
Mineral oils, untreated and mildly treated (Vol. 33, Suppl. 7; 1987)
Salted fish (Chinese-style) (Vol. 56; 1993)
Shale-oils [68308-34-9] (Vol. 35, Suppl. 7; 1987)
Soots (Vol. 35, Suppl. 7; 1987)
Tobacco products, smokeless (Vol. 37, Suppl. 7; 1987)
Tobacco smoke (Vol. 38, Suppl. 7; 1987)
Wood dust (Vol. 62; 1995)
Exposure circumstances
Aluminium production (Vol. 34, Suppl. 7; 1987)
Auramine, manufacture of (Suppl. 7; 1987)
Boot and shoe manufacture and repair (Vol. 25, Suppl. 7; 1987)
Coal gasification (Vol. 34, Suppl. 7; 1987)
Coke production (Vol. 34, Suppl. 7; 1987)
Furniture and cabinet making (Vol. 25, Suppl. 7; 1987)
Haematite mining (underground) with exposure to radon (Vol. 1, Suppl. 7;
1987)
Iron and steel founding (Vol. 34, Suppl. 7; 1987)
Isopropanol manufacture (strong-acid process) (Suppl. 7; 1987)
Magenta, manufacture of (Vol. 57; 1993)
Painter (occupational exposure as a) (Vol. 47; 1989)
Rubber industry (Vol. 28, Suppl. 7; 1987)
Strong-inorganic-acid mists containing sulfuric acid (occupational exposure
to) (Vol. 54; 1992)
----------------------------------------------------------------------------
Group 2A: Probably carcinogenic to humans (56)
Agents and groups of agents
Acrylamide [79-06-1] (Vol. 60; 1994)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Acrylonitrile [107-13-1] (Vol. 19, Suppl. 7; 1987)
Adriamycin [23214-92-8] (Vol. 10, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Androgenic (anabolic) steroids (Suppl. 7; 1987)
Azacitidine [320-67-2] (Vol. 50; 1990)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Benz[a]anthracene [56-55-3] (Vol. 32, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Benzidine-based dyes (Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Benzo[a]pyrene [50-32-8] (Vol. 32, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Bischloroethyl nitrosourea (BCNU) [154-93-8] (Vol. 26, Suppl. 7; 1987)
1,3-Butadiene [106-99-0] (Vol. 54; 1992)
Captafol [2425-06-1] (Vol. 53; 1991)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Chloramphenicol [56-75-7] (Vol. 50; 1990)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) [13010-47-4] (Vol. 26,
Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
para-Chloro-ortho-toluidine [95-69-2] and its strong acid salts (Vol. 48;
1990)
(NB: Evaluated as a group)
Chlorozotocin [54749-90-5] (Vol. 50; 1990)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Cisplatin [15663-27-1] (Vol. 26, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Clonorchis sinensis (infection with) (Vol. 61; 1994)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Dibenz[a,h]anthracene [53-70-3] (Vol. 32, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Diethyl sulfate [64-67-5] (Vol. 54; 1992)
Dimethylcarbamoyl chloride [79-44-7] (Vol. 12, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Dimethyl sulfate [77-78-1] (Vol. 4, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Epichlorohydrin [106-89-8] (Vol. 11, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Ethylene dibromide [106-93-4] (Vol. 15, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
N-Ethyl-N-nitrosourea [759-73-9] (Vol. 17, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Formaldehyde [50-00-0] (Vol. 62; 1995)
Human papillomavirus type 31 (Vol. 64; 1995)
Human papillomavirus type 33 (Vol. 64; 1995)
IQ (2-Amino-3-methylimidazo[4,5-f]quinoline) [76180-96-6] (Vol. 56; 1993)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
5-Methoxypsoralen [484-20-8] (Vol. 40, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
4,44-Methylene bis(2-chloroaniline) (MOCA) [101-14-4] (Vol. 57; 1993)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
N-Methyl-N4-nitro-N-nitrosoguanidine (MNNG) [70-25-7] (Vol. 4, Suppl. 7;
1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
N-Methyl-N-nitrosourea [684-93-5] (Vol. 17, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Nitrogen mustard [51-75-2] (Vol. 9, Suppl. 7; 1987)
N-Nitrosodiethylamine [55-18-5] (Vol. 17, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
N-Nitrosodimethylamine [62-75-9] (Vol. 17, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Phenacetin [62-44-2] (Vol. 24, Suppl. 7; 1987)
Procarbazine hydrochloride [366-70-1] (Vol. 26, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Styrene-7,8-oxide [96-09-3] (Vol. 60; 1994)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Tetrachloroethylene [127-18-4] (Vol. 63; 1995)
Trichloroethylene [79-01-6] (Vol. 63; 1995)
1,2,3-Trichloropropane [96-18-4] (Vol. 63; 1995)
Tris(2,3-dibromopropyl)phosphate [126-72-7] (Vol. 20, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Ultraviolet radiation A (Vol. 55; 1992)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Ultraviolet radiation B (Vol. 55; 1992)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Ultraviolet radiation C (Vol. 55; 1992)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Vinyl bromide [593-60-2] (Vol. 39, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 2B to 2A with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Vinyl fluoride [75-02-5] (Vol. 63; 1995)
Mixtures
Creosotes [8001-58-9] (Vol. 35, Suppl. 7; 1987)
Diesel engine exhaust (Vol. 46; 1989)
Hot mate (Vol. 51; 1991)
Non-arsenical insecticides (occupational exposures in spraying and
application of) (Vol. 53; 1991)
Polychlorinated biphenyls [1336-36-3] (Vol. 18, Suppl. 7; 1987)
Exposure circumstances
Art glass, glass containers and pressed ware (manufacture of) (Vol. 58;
1993)
Hairdresser or barber (occupational exposure as a) (Vol. 57; 1993)
Petroleum refining (occupational exposures in) (Vol. 45; 1989)
Sunlamps and sunbeds (use of) (Vol. 55; 1992)
----------------------------------------------------------------------------
Group 2B: Possibly carcinogenic to humans (225)
Agents and groups of agents
A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole) [26148-68-5] (Vol. 40, Suppl. 7;
1987)
Acetaldehyde [75-07-0] (Vol. 36, Suppl. 7; 1987)
Acetamide [60-35-5] (Vol. 7, Suppl. 7; 1987)
AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide] [3688-53-7] (Vol. 31,
Suppl. 7; 1987)
Aflatoxin M1 [6795-23-9] (Vol. 56; 1993)
para-Aminoazobenzene [60-09-3] (Vol. 8, Suppl. 7; 1987)
ortho-Aminoazotoluene [97-56-3] (Vol. 8, Suppl. 7; 1987)
2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole [712-68-5] (Vol. 7, Suppl. 7;
1987)
Amitrole [61-82-5] (Vol. 41, Suppl. 7; 1987)
ortho-Anisidine [90-04-0] (Vol. 27, Suppl. 7; 1987)
Antimony trioxide [1309-64-4] (Vol. 47; 1989)
Aramite. [140-57-8] (Vol. 5, Suppl. 7; 1987)
Atrazine [1912-24-9] (Vol. 53; 1991)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Auramine [492-80-8] (technical-grade) (Vol. 1, Suppl. 7; 1987)
Azaserine [115-02-6] (Vol. 10, Suppl. 7; 1987)
Benzo[b]fluoranthene [205-99-2] (Vol. 32, Suppl. 7; 1987)
Benzo[j]fluoranthene [205-82-3] (Vol. 32, Suppl. 7; 1987)
Benzo[k]fluoranthene [207-08-9] (Vol. 32, Suppl. 7; 1987)
Benzofuran [271-89-6] (Vol. 63; 1995)
Benzyl violet 4B [1694-09-3] (Vol. 16, Suppl. 7; 1987)
Bleomycins [11056-06-7] (Vol. 26, Suppl. 7; 1987)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Bracken fern (Vol. 40, Suppl. 7; 1987)
Bromodichloromethane [75-27-4] (Vol. 52; 1991)
Butylated hydroxyanisole (BHA) [25013-16-5] (Vol. 40, Suppl. 7; 1987)
beta-Butyrolactone [3068-88-0] (Vol. 11, Suppl. 7; 1987)
Caffeic acid [331-39-5] (Vol. 56; 1993)
Carbon black [1333-86-4] (Vol. 65; 1996)
Carbon tetrachloride [56-23-5] (Vol. 20, Suppl. 7; 1987)
Ceramic fibres (Vol. 43; 1988)
Chlordane [57-74-9] (Vol. 53; 1991)
Chlordecone (Kepone) [143-50-0] (Vol. 20, Suppl. 7; 1987)
Chlorendic acid [115-28-6] (Vol. 48; 1990)
alpha-Chlorinated toluenes (benzyl chloride, benzal chloride,
benzotrichloride) (Suppl. 7; 1987)
para-Chloroaniline [106-47-8] (Vol. 57; 1993)
Chloroform [67-66-3] (Vol. 20, Suppl. 7; 1987)
1-Chloro-2-methylpropene [513-37-1] (Vol. 63; 1995)
Chlorophenols (Vol. 41, Suppl. 7; 1987)
Chlorophenoxy herbicides (Vol. 41, Suppl. 7; 1987)
4-Chloro-ortho-phenylenediamine [95-83-0] (Vol. 27, Suppl. 7; 1987)
CI Acid Red 114 [6459-94-5] (Vol. 57; 1993)
CI Basic Red 9 [569-61-9] (Vol. 57; 1993)
CI Direct Blue 15 [2429-74-5] (Vol. 57; 1993)
Citrus Red No. 2 [6358-53-8] (Vol. 8, Suppl. 7; 1987)
Cobalt [7440-48-4] and cobalt compounds (Vol. 52; 1991)
(NB: Evaluated as a group)
para-Cresidine [120-71-8] (Vol. 27, Suppl. 7; 1987)
Cycasin [14901-08-7] (Vol. 10, Suppl. 7; 1987)
Dacarbazine [4342-03-4] (Vol. 26, Suppl. 7; 1987)
Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone) [117-10-2] (Vol. 50; 1990)
Daunomycin [20830-81-3] (Vol. 10, Suppl. 7; 1987)
DDT [p,p'-DDT, 50-29-3] (Vol. 53; 1991)
N,N'-Diacetylbenzidine [613-35-4] (Vol. 16, Suppl. 7; 1987)
2,4-Diaminoanisole [615-05-4] (Vol. 27, Suppl. 7; 1987)
4,4'-Diaminodiphenyl ether [101-80-4] (Vol. 29, Suppl. 7; 1987)
2,4-Diaminotoluene [95-80-7] (Vol. 16, Suppl. 7; 1987)
Dibenz[a,h]acridine [226-36-8] (Vol. 32, Suppl. 7; 1987)
Dibenz[a,j]acridine [224-42-0] (Vol. 32, Suppl. 7; 1987)
7H-Dibenzo[c,g]carbazole [194-59-2] (Vol. 32, Suppl. 7; 1987)
Dibenzo[a,e]pyrene [192-65-4] (Vol. 32, Suppl. 7; 1987)
Dibenzo[a,h]pyrene [189-64-0] (Vol. 32, Suppl. 7; 1987)
Dibenzo[a,i]pyrene [189-55-9] (Vol. 32, Suppl. 7; 1987)
Dibenzo[a,l]pyrene [191-30-0] (Vol. 32, Suppl. 7; 1987)
1,2-Dibromo-3-chloropropane [96-12-8] (Vol. 20, Suppl. 7; 1987)
para-Dichlorobenzene [106-46-7] (Vol. 29, Suppl. 7; 1987)
3,3'-Dichlorobenzidine [91-94-1] (Vol. 29, Suppl. 7; 1987)
3,3'-Dichloro-4,4'-diaminodiphenyl ether [28434-86-8] (Vol. 16, Suppl. 7;
1987)
1,2-Dichloroethane [107-06-2] (Vol. 20, Suppl. 7; 1987)
Dichloromethane (methylene chloride) [75-09-2] (Vol. 41, Suppl. 7; 1987)
1,3-Dichloropropene [542-75-6] (technical-grade) (Vol. 41, Suppl. 7; 1987)
Dichlorvos [62-73-7] (Vol. 53; 1991)
Diepoxybutane [1464-53-5] (Vol. 11, Suppl. 7; 1987)
Di(2-ethylhexyl)phthalate [117-81-7] (Vol. 29, Suppl. 7; 1987)
1,2-Diethylhydrazine [1615-80-1] (Vol. 4, Suppl. 7; 1987)
Diglycidyl resorcinol ether [101-90-6] (Vol. 36, Suppl. 7; 1987)
Dihydrosafrole [94-58-6] (Vol. 10, Suppl. 7; 1987)
Diisopropyl sulfate [2973-10-6] (Vol. 54; 1992)
3,3'-Dimethoxybenzidine (ortho-Dianisidine) [119-90-4] (Vol. 4, Suppl. 7;
1987)
para-Dimethylaminoazobenzene [60-11-7] (Vol. 8, Suppl. 7; 1987)
trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)-vinyl]-1,3,4-oxadiazole
[25962-77-0]
(Vol. 7, Suppl. 7; 1987)
2,6-Dimethylaniline (2,6-Xylidine) [87-62-7] (Vol. 57; 1993)
3,3'-Dimethylbenzidine (ortho-Tolidine) [119-93-7] (Vol. 1, Suppl. 7; 1987)
Dimethylformamide [68-12-2] (Vol. 47; 1989)
1,1-Dimethylhydrazine [57-14-7] (Vol. 4, Suppl. 7; 1987)
1,2-Dimethylhydrazine [540-73-8] (Vol. 4, Suppl. 7; 1987)
3,7-Dinitrofluoranthene [105735-71-5] (Vol. 65; 1996)
3,9-Dinitrofluoranthene [22506-53-2] (Vol. 65; 1996)
1,6-Dinitropyrene [42397-64-8] (Vol. 46; 1989)
1,8-Dinitropyrene [42397-65-9] (Vol. 46; 1989)
2,4-Dinitrotoluene [121-14-2] (Vol. 65; 1996)
2,6-Dinitrotoluene [606-20-2] (Vol. 65; 1996)
1,4-Dioxane [123-91-1] (Vol. 11, Suppl. 7; 1987)
Disperse Blue 1 [2475-45-8] (Vol. 48; 1990)
Ethyl acrylate [140-88-5] (Vol. 39, Suppl. 7; 1987)
Ethylene thiourea [96-45-7] (Vol. 7, Suppl. 7; 1987)
Ethyl methanesulfonate [62-50-0] (Vol. 7, Suppl. 7; 1987)
2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole [3570-75-0] (Vol. 7,
Suppl. 7; 1987)
Furan [110-00-9] (Vol. 63; 1995)
Glasswool (Vol. 43; 1988)
Glu-P-1 (2-Amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole) [67730-11-4]
(Vol. 40, Suppl. 7; 1987)
Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole) [67730-10-3] (Vol. 40,
Suppl. 7; 1987)
Glycidaldehyde [765-34-4] (Vol. 11, Suppl. 7; 1987)
Griseofulvin [126-07-8] (Vol. 10, Suppl. 7; 1987)
HC Blue No. 1 [2784-94-3] (Vol. 57; 1993)
Heptachlor [76-44-8] (Vol. 53; 1991)
Hexachlorobenzene [118-74-1] (Vol. 20, Suppl. 7; 1987)
Hexachlorocyclohexanes (Vol. 20, Suppl. 7; 1987)
Hexamethylphosphoramide [680-31-9] (Vol. 15, Suppl. 7; 1987)
Human immunodeficiency virus type 2 (infection with) (Vol. 67; 1996)
Human papillomaviruses: some types other than 16, 18, 31 and 33 (Vol. 64;
1995)
Hydrazine [302-01-2] (Vol. 4, Suppl. 7; 1987)
Indeno[1,2,3-cd]pyrene [193-39-5] (Vol. 32, Suppl. 7; 1987)
Iron-dextran complex [9004-66-4] (Vol. 2, Suppl. 7; 1987)
Isoprene [78-79-5] (Vol. 60; 1994)
Lasiocarpine [303-34-4] (Vol. 10, Suppl. 7; 1987)
Lead [7439-92-1] and lead compounds, inorganic (Vol. 23, Suppl. 7; 1987)
(NB: Evaluated as a group)
Magenta [632-99-5] (containing CI Basic Red 9) (Vol. 57; 1993)
MeA-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) [68006-83-7] (Vol. 40,
Suppl. 7; 1987)
Medroxyprogesterone acetate [71-58-9] (Vol. 21, Suppl. 7; 1987)
MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) [77094-11-2] (Vol. 56;
1993)
MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) [77500-04-0] (Vol. 56;
1993)
Merphalan [531-76-0] (Vol. 9, Suppl. 7; 1987)
2-Methylaziridine (Propyleneimine) [75-55-8] (Vol. 9, Suppl. 7; 1987)
Methylazoxymethanol acetate [592-62-1] (Vol. 10, Suppl. 7; 1987)
5-Methylchrysene [3697-24-3] (Vol. 32, Suppl. 7; 1987)
4,4'-Methylene bis(2-methylaniline) [838-88-0] (Vol. 4, Suppl. 7; 1987)
4,4'-Methylenedianiline [101-77-9] (Vol. 39, Suppl. 7; 1987)
Methylmercury compounds (Vol. 58; 1993)
(NB: Evaluated as a group)
Methyl methanesulfonate [66-27-3] (Vol. 7, Suppl. 7; 1987)
2-Methyl-1-nitroanthraquinone [129-15-7] (uncertain purity) (Vol. 27, Suppl.
7; 1987)
N-Methyl-N-nitrosourethane [615-53-2] (Vol. 4, Suppl. 7; 1987)
Methylthiouracil [56-04-2] (Vol. 7, Suppl. 7; 1987)
Metronidazole [443-48-1] (Vol. 13, Suppl. 7; 1987)
Mirex [2385-85-5] (Vol. 20, Suppl. 7; 1987)
Mitomycin C [50-07-7] (Vol. 10, Suppl. 7; 1987)
Monocrotaline [315-22-0] (Vol. 10, Suppl. 7; 1987)
5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)amino]-2-oxazolidinone
[3795-88-8] (Vol. 7, Suppl. 7; 1987)
Nafenopin [3771-19-5] (Vol. 24, Suppl. 7; 1987)
Nickel, metallic [7440-02-0] and alloys (Vol. 49; 1990)
Niridazole [61-57-4] (Vol. 13, Suppl. 7; 1987)
Nitrilotriacetic acid [139-13-9] and its salts (Vol. 48; 1990)
(NB: Evaluated as a group)
5-Nitroacenaphthene [602-87-9] (Vol. 16, Suppl. 7; 1987)
2-Nitroanisole [91-23-6] (Vol. 65; 1996)
Nitrobenzene [98-95-3] (Vol. 65; 1996)
6-Nitrochrysene [7496-02-8] (Vol. 46; 1989)
Nitrofen [1836-75-5] (technical-grade) (Vol. 30, Suppl. 7; 1987)
2-Nitrofluorene [607-57-8] (Vol. 46; 1989)
1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone [555-84-0] (Vol. 7, Suppl.
7; 1987)
N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide [531-82-8] (Vol. 7, Suppl. 7;
1987)
Nitrogen mustard N-oxide [126-85-2] (Vol. 9, Suppl. 7; 1987)
2-Nitropropane [79-46-9] (Vol. 29, Suppl. 7; 1987)
1-Nitropyrene [5522-43-0] (Vol. 46; 1989)
4-Nitropyrene [57835-92-4] (Vol. 46; 1989)
N-Nitrosodi-n-butylamine [924-16-3] (Vol. 17, Suppl. 7; 1987)
N-Nitrosodiethanolamine [1116-54-7] (Vol. 17, Suppl. 7; 1987)
N-Nitrosodi-n-propylamine [621-64-7] (Vol. 17, Suppl. 7; 1987)
3-(N-Nitrosomethylamino)propionitrile [60153-49-3] (Vol. 37, Suppl. 7; 1987)
4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) [64091-91-4] (Vol.
37, Suppl. 7; 1987)
N-Nitrosomethylethylamine [10595-95-6] (Vol. 17, Suppl. 7; 1987)
N-Nitrosomethylvinylamine [4549-40-0] (Vol. 17, Suppl. 7; 1987)
N-Nitrosomorpholine [59-89-2] (Vol. 17, Suppl. 7; 1987)
N'-Nitrosonornicotine [16543-55-8] (Vol. 37, Suppl. 7; 1987)
N-Nitrosopiperidine [100-75-4] (Vol. 17, Suppl. 7; 1987)
N-Nitrosopyrrolidine [930-55-2] (Vol. 17, Suppl. 7; 1987)
N-Nitrososarcosine [13256-22-9] (Vol. 17, Suppl. 7; 1987)
Ochratoxin A [303-47-9] (Vol. 56; 1993)
Oil Orange SS [2646-17-5] (Vol. 8, Suppl. 7; 1987)
Oxazepam [604-75-1] (Vol. 66; 1996)
Palygorskite (attapulgite) [12174-11-7] (long fibres, > 5 micrometers) (Vol.
68; 1997)
Panfuran S (containing dihydroxymethylfuratrizine [794-93-4]) (Vol. 24,
Suppl. 7; 1987)
Pentachlorophenol [87-86-5] (Vol. 53; 1991)
Phenazopyridine hydrochloride [136-40-3] (Vol. 24, Suppl. 7; 1987)
Phenobarbital [50-06-6] (Vol. 13, Suppl. 7; 1987)
Phenoxybenzamine hydrochloride [63-92-3] (Vol. 24, Suppl. 7; 1987)
Phenyl glycidyl ether [122-60-1] (Vol. 47; 1989)
Phenytoin [57-41-0] (Vol. 66; 1996)
PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) [105650-23-5] (Vol.
56; 1993)
Ponceau MX [3761-53-3] (Vol. 8, Suppl. 7; 1987)
Ponceau 3R [3564-09-8] (Vol. 8, Suppl. 7; 1987)
Potassium bromate [7758-01-2] (Vol. 40, Suppl. 7; 1987)
Progestins (Suppl. 7; 1987)
1,3-Propane sultone [1120-71-4] (Vol. 4, Suppl. 7; 1987)
beta-Propiolactone [57-57-8] (Vol. 4, Suppl. 7; 1987)
Propylene oxide [75-56-9] (Vol. 60; 1994)
Propylthiouracil [51-52-5] (Vol. 7, Suppl. 7; 1987)
Rockwool (Vol. 43; 1988)
Saccharin [81-07-2] (Vol. 22, Suppl. 7; 1987)
Safrole [94-59-7] (Vol. 10, Suppl. 7; 1987)
Schistosoma japonicum (infection with) (Vol. 61; 1994)
Slagwool (Vol. 43; 1988)
Sodium ortho-phenylphenate [132-27-4] (Vol. 30, Suppl. 7; 1987)
Sterigmatocystin [10048-13-2] (Vol. 10, Suppl. 7; 1987)
Streptozotocin [18883-66-4] (Vol. 17, Suppl. 7; 1987)
Styrene [100-42-5] (Vol. 60; 1994)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Sulfallate [95-06-7] (Vol. 30, Suppl. 7; 1987)
Tetranitromethane [509-14-8] (Vol. 65; 1996)
Thioacetamide [62-55-5] (Vol. 7, Suppl. 7; 1987)
4,4'-Thiodianiline [139-65-1] (Vol. 27, Suppl. 7; 1987)
Thiourea [62-56-6] (Vol. 7, Suppl. 7; 1987)
Toluene diisocyanates [26471-62-5] (Vol. 39, Suppl. 7; 1987)
ortho-Toluidine [95-53-4] (Vol. 27, Suppl. 7; 1987)
Trichlormethine (Trimustine hydrochloride) [817-09-4] (Vol. 50; 1990)
Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole) [62450-06-0] (Vol. 31,
Suppl. 7; 1987)
Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole) [62450-07-1] (Vol. 31,
Suppl. 7; 1987)
Trypan blue [72-57-1] (Vol. 8, Suppl. 7; 1987)
Uracil mustard [66-75-1] (Vol. 9, Suppl. 7; 1987)
Urethane [51-79-6] (Vol. 7, Suppl. 7; 1987)
Vinyl acetate [108-05-4] (Vol. 63; 1995)
4-Vinylcyclohexene [100-40-3] (Vol. 60; 1994)
4-Vinylcyclohexene diepoxide [106-87-6] (Vol. 60; 1994)
Mixtures
Bitumens [8052-42-4], extracts of steam-refined and air-refined (Vol. 35,
Suppl. 7; 1987)
Carrageenan [9000-07-1], degraded (Vol. 31, Suppl. 7; 1987)
Chlorinated paraffins of average carbon chain length C12 and average degree
of chlorination approximately 60%
(Vol. 48; 1990)
Coffee (urinary bladder) (Vol. 51; 1991)
(NB: There is some evidence of an inverse relationship between coffee
drinking and cancer of the large bowel; coffee drinking could not be
classified as to its carcinogenicity to other organs)
Diesel fuel, marine (Vol. 45; 1989)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Engine exhaust, gasoline (Vol. 46; 1989)
Fuel oils, residual (heavy) (Vol. 45; 1989)
Gasoline (Vol. 45; 1989)
(NB: Overall evaluation upgraded from 3 to 2B with supporting evidence from
other data relevant to the evaluation of carcinogenicity and its mechanisms)
Pickled vegetables (traditional in Asia) (Vol. 56; 1993)
Polybrominated biphenyls [Firemaster BP-6, 59536-65-1] (Vol. 41, Suppl. 7;
1987)
Toxaphene (Polychlorinated camphenes) [8001-35-2] (Vol. 20, Suppl. 7; 1987)
Toxins derived from Fusarium moniliforme (Vol. 56; 1993)
Welding fumes (Vol. 49; 1990)
Exposure circumstances
Carpentry and joinery (Vol. 25, Suppl. 7; 1987)
Dry cleaning (occupational exposures in) (Vol. 63; 1995)
Printing processes (occupational exposures in) (Vol. 65; 1996)
Textile manufacturing industry (work in) (Vol. 48; 1990)
----------------------------------------------------------------------------
Group 3: Unclassifiable as to carcinogenicity to humans (480)
Agents and groups of agents
Acridine orange [494-38-2] (Vol. 16, Suppl. 7; 1987)
Acriflavinium chloride [8018-07-3] (Vol. 13, Suppl. 7; 1987)
Acrolein [107-02-8] (Vol. 63; 1995)
Acrylic acid [79-10-7] (Vol. 19, Suppl. 7; 1987)
Acrylic fibres (Vol. 19, Suppl. 7; 1987)
Acrylonitrile-butadiene-styrene copolymers (Vol. 19, Suppl. 7; 1987)
Actinomycin D [50-76-0] (Vol. 10, Suppl. 7; 1987)
Agaritine [2757-90-6] (Vol. 31, Suppl. 7; 1987)
Aldicarb [116-06-3] (Vol. 53; 1991)
Aldrin [309-00-2] (Vol. 5, Suppl. 7; 1987)
Allyl chloride [107-05-1] (Vol. 36, Suppl. 7; 1987)
Allyl isothiocyanate [57-06-7] (Vol. 36, Suppl. 7; 1987)
Allyl isovalerate [2835-39-4] (Vol. 36, Suppl. 7; 1987)
Amaranth [915-67-3] (Vol. 8, Suppl. 7; 1987)
5-Aminoacenaphthene [4657-93-6] (Vol. 16, Suppl. 7; 1987)
2-Aminoanthraquinone [117-79-3] (Vol. 27, Suppl. 7; 1987)
para-Aminobenzoic acid [150-13-0] (Vol. 16, Suppl. 7; 1987)
1-Amino-2-methylanthraquinone [82-28-0] (Vol. 27, Suppl. 7; 1987)
2-Amino-4-nitrophenol [99-57-0] (Vol. 57; 1993)
2-Amino-5-nitrophenol [121-88-0] (Vol. 57; 1993)
4-Amino-2-nitrophenol [119-34-6] (Vol. 16, Suppl. 7; 1987)
2-Amino-5-nitrothiazole [121-66-4] (Vol. 31, Suppl. 7; 1987)
11-Aminoundecanoic acid [2432-99-7] (Vol. 39, Suppl. 7; 1987)
Ampicillin [69-53-4] (Vol. 50; 1990)
Anaesthetics, volatile (Vol. 11, Suppl. 7; 1987)
Angelicin [523-50-2] plus ultraviolet A radiation (Vol. 40, Suppl. 7; 1987)
Aniline [62-53-3] (Vol. 27, Suppl. 7; 1987)
para-Anisidine [104-94-9] (Vol. 27, Suppl. 7; 1987)
Anthanthrene [191-26-4] (Vol. 32, Suppl. 7; 1987)
Anthracene [120-12-7] (Vol. 32, Suppl. 7; 1987)
Anthranilic acid [118-92-3] (Vol. 16, Suppl. 7; 1987)
Antimony trisulfide [1345-04-6] (Vol. 47; 1989)
Apholate [52-46-0] (Vol. 9, Suppl. 7; 1987)
para-Aramid fibrils [24938-64-5] (Vol. 68; 1997)
Aurothioglucose [12192-57-3] (Vol. 13, Suppl. 7; 1987)
Aziridine [151-56-4] (Vol. 9, Suppl. 7; 1987)
2-(1-Aziridinyl)ethanol [1072-52-2] (Vol. 9, Suppl. 7; 1987)
Aziridyl benzoquinone [800-24-8] (Vol. 9, Suppl. 7; 1987)
Azobenzene [103-33-3] (Vol. 8, Suppl. 7; 1987)
Benz[a]acridine [225-11-6] (Vol. 32, Suppl. 7; 1987)
Benz[c]acridine [225-51-4] (Vol. 32, Suppl. 7; 1987)
Benzo[ghi]fluoranthene [203-12-3] (Vol. 32, Suppl. 7; 1987)
Benzo[a]fluorene [238-84-6] (Vol. 32, Suppl. 7; 1987)
Benzo[b]fluorene [243-17-4] (Vol. 32, Suppl. 7; 1987)
Benzo[c]fluorene [205-12-9] (Vol. 32, Suppl. 7; 1987)
Benzo[ghi]perylene [191-24-2] (Vol. 32, Suppl. 7; 1987)
Benzo[c]phenanthrene [195-19-7] (Vol. 32, Suppl. 7; 1987)
Benzo[e]pyrene [192-97-2] (Vol. 32, Suppl. 7; 1987)
para-Benzoquinone dioxime [105-11-3] (Vol. 29, Suppl. 7; 1987)
Benzoyl chloride [98-88-4] (Vol. 29, Suppl. 7; 1987)
Benzoyl peroxide [94-36-0] (Vol. 36, Suppl. 7; 1987)
Benzyl acetate [140-11-4] (Vol. 40, Suppl. 7; 1987)
Bis(1-aziridinyl)morpholinophosphine sulfide [2168-68-5] (Vol. 9, Suppl. 7;
1987)
Bis(2-chloroethyl)ether [111-44-4] (Vol. 9, Suppl. 7; 1987)
1,2-Bis(chloromethoxy)ethane [13483-18-6] (Vol. 15, Suppl. 7; 1987)
1,4-Bis(chloromethoxymethyl)benzene [56894-91-8] (Vol. 15, Suppl. 7; 1987)
Bis(2-chloro-1-methylethyl)ether [108-60-1] (Vol. 41, Suppl. 7; 1987)
Bis(2,3-epoxycyclopentyl)ether [2386-90-5] (Vol. 47; 1989)
Bisphenol A diglycidyl ether [1675-54-3] (Vol. 47; 1989)
Bisulfites (Vol. 54; 1992)
Blue VRS [129-17-9] (Vol. 16, Suppl. 7; 1987)
Brilliant Blue FCF, disodium salt [3844-45-9] (Vol. 16, Suppl. 7; 1987)
Bromochloroacetonitrile [83463-62-1] (Vol. 52; 1991)
Bromoethane [74-96-4] (Vol. 52; 1991)
Bromoform [75-25-2] (Vol. 52; 1991)
n-Butyl acrylate [141-32-2] (Vol. 39, Suppl. 7; 1987)
Butylated hydroxytoluene (BHT) [128-37-0] (Vol. 40, Suppl. 7; 1987)
Butyl benzyl phthalate [85-68-7] (Vol. 29, Suppl. 7; 1987)
gamma-Butyrolactone [96-48-0] (Vol. 11, Suppl. 7; 1987)
Caffeine [58-08-2] (Vol. 51; 1991)
Cantharidin [56-25-7] (Vol. 10, Suppl. 7; 1987)
Captan [133-06-2] (Vol. 30, Suppl. 7; 1987)
Carbaryl [63-25-2] (Vol. 12, Suppl. 7; 1987)
Carbazole [86-74-8] (Vol. 32, Suppl. 7; 1987)
3-Carbethoxypsoralen [20073-24-9] (Vol. 40, Suppl. 7; 1987)
Carmoisine [3567-69-9] (Vol. 8, Suppl. 7; 1987)
Carrageenan [9000-07-1], native (Vol. 31, Suppl. 7; 1987)
Catechol [120-80-9] (Vol. 15, Suppl. 7; 1987)
Chloral [75-87-6] (Vol. 63; 1995)
Chloral hydrate [302-17-0] (Vol. 63; 1995)
Chlordimeform [6164-98-3] (Vol. 30, Suppl. 7; 1987)
Chlorinated dibenzodioxins (other than TCDD) (Vol. 15, Suppl. 7; 1987)
Chlorinated drinking-water (Vol. 52; 1991)
Chloroacetonitrile [107-14-2] (Vol. 52; 1991)
Chlorobenzilate [510-15-6] (Vol. 30, Suppl. 7; 1987)
Chlorodibromomethane [124-48-1] (Vol. 52; 1991)
Chlorodifluoromethane [75-45-6] (Vol. 41, Suppl. 7; 1987)
Chloroethane [75-00-3] (Vol. 52; 1991)
Chlorofluoromethane [593-70-4] (Vol. 41, Suppl. 7; 1987)
3-Chloro-2-methylpropene [563-47-3] (Vol. 63; 1995)
4-Chloro-meta-phenylenediamine [5131-60-2] (Vol. 27, Suppl. 7; 1987)
Chloronitrobenzenes [88-73-3; 121-73-3; 100-00-5] (Vol. 65; 1996)
Chloroprene [126-99-8] (Vol. 19, Suppl. 7; 1987)
Chloropropham [101-21-3] (Vol. 12, Suppl. 7; 1987)
Chloroquine [54-05-7] (Vol. 13, Suppl. 7; 1987)
Chlorothalonil [1897-45-6] (Vol. 30, Suppl. 7; 1987)
2-Chloro-1,1,1-trifluoroethane [75-88-7] (Vol. 41, Suppl. 7; 1987)
Cholesterol [57-88-5] (Vol. 31, Suppl. 7; 1987)
Chromium[III] compounds (Vol. 49; 1990)
Chromium [7440-47-3], metallic (Vol. 49; 1990)
Chrysene [218-01-9] (Vol. 32, Suppl. 7; 1987)
Chrysoidine [532-82-1] (Vol. 8, Suppl. 7; 1987)
CI Acid Orange 3 [6373-74-6] (Vol. 57; 1993)
Cimetidine [51481-61-9] (Vol. 50; 1990)
Cinnamyl anthranilate [87-29-6] (Vol. 31, Suppl. 7; 1987)
CI Pigment Red 3 [2425-85-6] (Vol. 57; 1993)
Citrinin [518-75-2] (Vol. 40, Suppl. 7; 1987)
Clofibrate [637-07-0] (Vol. 66; 1996)
Clomiphene citrate [50-41-9] (Vol. 21, Suppl. 7; 1987)
Coal dust (Vol. 68; 1997)
Copper 8-hydroxyquinoline [10380-28-6] (Vol. 15, Suppl. 7; 1987)
Coronene [191-07-1] (Vol. 32, Suppl. 7; 1987)
Coumarin [91-64-5] (Vol. 10, Suppl. 7; 1987)
meta-Cresidine [102-50-1] (Vol. 27, Suppl. 7; 1987)
Crotonaldehyde [4170-30-3] (Vol. 63; 1995)
Cyclamates [sodium cyclamate, 139-05-9] (Vol. 22, Suppl. 7; 1987)
Cyclochlorotine [12663-46-6] (Vol. 10, Suppl. 7; 1987)
Cyclohexanone [108-94-1] (Vol. 47; 1989)
Cyclopenta[cd]pyrene [27208-37-3] (Vol. 32, Suppl. 7; 1987)
D & C Red No. 9 [5160-02-1] (Vol. 57; 1993)
Dapsone [80-08-0] (Vol. 24, Suppl. 7; 1987)
Decabromodiphenyl oxide [1163-19-5] (Vol. 48; 1990)
Deltamethrin [52918-63-5] (Vol. 53; 1991)
Diacetylaminoazotoluene [83-63-6] (Vol. 8, Suppl. 7; 1987)
Diallate [2303-16-4] (Vol. 30, Suppl. 7; 1987)
1,2-Diamino-4-nitrobenzene [99-56-9] (Vol. 16, Suppl. 7; 1987)
1,4-Diamino-2-nitrobenzene [5307-14-2] (Vol. 57; 1993)
2,5-Diaminotoluene [95-70-5] (Vol. 16, Suppl. 7; 1987)
Diazepam [439-14-5] (Vol. 66; 1996)
Diazomethane [334-88-3] (Vol. 7, Suppl. 7; 1987)
Dibenz[a,c]anthracene [215-58-7] (Vol. 32, Suppl. 7; 1987)
Dibenz[a,j]anthracene [224-41-9] (Vol. 32, Suppl. 7; 1987)
Dibenzo-para-dioxin (Vol. 69; 1997)
Dibenzo[a,e]fluoranthene [5385-75-1] (Vol. 32, Suppl. 7; 1987)
Dibenzo[h,rst]pentaphene [192-47-2] (Vol. 3, Suppl. 7; 1987)
Dibromoacetonitrile [3252-43-5] (Vol. 52; 1991)
Dichloroacetic acid [79-43-6] (Vol. 63; 1995)
Dichloroacetonitrile [3018-12-0] (Vol. 52; 1991)
Dichloroacetylene [7572-29-4] (Vol. 39, Suppl. 7; 1987)
ortho-Dichlorobenzene [95-50-1] (Vol. 29, Suppl. 7; 1987)
trans-1,4-Dichlorobutene [110-57-6] (Vol. 15, Suppl. 7; 1987)
2,6-Dichloro-para-phenylenediamine [609-20-1] (Vol. 39, Suppl. 7; 1987)
1,2-Dichloropropane [78-87-5] (Vol. 41, Suppl. 7; 1987)
Dicofol [115-32-2] (Vol. 30, Suppl. 7; 1987)
Dieldrin [60-57-1] (Vol. 5, Suppl. 7; 1987)
Di(2-ethylhexyl)adipate [103-23-1] (Vol. 29, Suppl. 7; 1987)
Dihydroxymethylfuratrizine [794-93-4] (Vol. 24, Suppl. 7; 1987)
Dimethoxane [828-00-2] (Vol. 15, Suppl. 7; 1987)
3,3'-Dimethoxybenzidine-4,4'-diisocyanate [91-93-0] (Vol. 39, Suppl. 7;
1987)
para-Dimethylaminoazobenzenediazo sodium sulfonate [140-56-7] (Vol. 8,
Suppl. 7; 1987)
4,4'-Dimethylangelicin [22975-76-4] plus ultraviolet A radiation (Suppl. 7;
1987)
4,5'-Dimethylangelicin [4063-41-6] plus ultraviolet A radiation (Suppl. 7;
1987)
N,N-Dimethylaniline [121-69-7] (Vol. 57; 1993)
Dimethyl hydrogen phosphite [868-85-9] (Vol. 48; 1990)
1,4-Dimethylphenanthrene [22349-59-3] (Vol. 32, Suppl. 7; 1987)
1,3-Dinitropyrene [75321-20-9] (Vol. 46; 1989)
3,5-Dinitrotoluene [618-85-9] (Vol. 65; 1996)
Dinitrosopentamethylenetetramine [101-25-7] (Vol. 11, Suppl. 7; 1987)
2,4'-Diphenyldiamine [492-17-1] (Vol. 16, Suppl. 7; 1987)
Disperse Yellow 3 [2832-40-8] (Vol. 48; 1990)
Disulfiram [97-77-8] (Vol. 12, Suppl. 7; 1987)
Dithranol [1143-38-0] (Vol. 13; Suppl. 7; 1987)
Doxefazepam [40762-15-0] (Vol. 66; 1996)
Droloxifene [82413-20-5] (Vol. 66; 1996)
Dulcin [150-69-6] (Vol. 12, Suppl. 7; 1987)
Endrin [72-20-8] (Vol. 5, Suppl. 7; 1987)
Eosin [15086-94-9] (Vol. 15, Suppl. 7; 1987)
1,2-Epoxybutane [106-88-7] (Vol. 47; 1989)
3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclo-hexane
carboxylate [141-37-7]
(Vol. 11, Suppl. 7; 1987)
cis-9,10-Epoxystearic acid [2443-39-2] (Vol. 11, Suppl. 7; 1987)
Estazolam [29975-16-4] (Vol. 66; 1996)
Ethionamide [536-33-4] (Vol. 13, Suppl. 7; 1987)
Ethylene [74-85-1] (Vol. 60; 1994)
Ethylene sulfide [420-12-2] (Vol. 11, Suppl. 7; 1987)
2-Ethylhexyl acrylate [103-11-7] (Vol. 60; 1994)
Ethyl selenac [5456-28-0] (Vol. 12, Suppl. 7; 1987)
Ethyl tellurac [20941-65-5] (Vol. 12, Suppl. 7; 1987)
Eugenol [97-53-0] (Vol. 36, Suppl. 7; 1987)
Evans blue [314-13-6] (Vol. 8, Suppl. 7; 1987)
Fast Green FCF [2353-45-9] (Vol. 16, Suppl. 7; 1987)
Fenvalerate [51630-58-1] (Vol. 53; 1991)
Ferbam [14484-64-1] (Vol. 12, Suppl. 7; 1987)
Ferric oxide [1309-37-1] (Vol. 1, Suppl. 7; 1987)
Fluometuron [2164-17-2] (Vol. 30, Suppl. 7; 1987)
Fluoranthene [206-44-0] (Vol. 32, Suppl. 7; 1987)
Fluorene [86-73-7] (Vol. 32, Suppl. 7; 1987)
Fluorescent lighting (Vol. 55; 1992)
Fluorides (inorganic, used in drinking-water) (Vol. 27, Suppl. 7; 1987)
5-Fluorouracil [51-21-8] (Vol. 26, Suppl. 7; 1987)
Furazolidone [67-45-8] (Vol. 31, Suppl. 7; 1987)
Furfural [98-01-1] (Vol. 63; 1995)
Furosemide (Frusemide) [54-31-9] (Vol. 50; 1990)
Gemfibrozil [25812-30-0] (Vol. 66; 1996)
Glass filaments (Vol. 43; 1988)
Glycidyl oleate [5431-33-4] (Vol. 11, Suppl. 7; 1987)
Glycidyl stearate [7460-84-6] (Vol. 11, Suppl. 7; 1987)
Guinea Green B [4680-78-8] (Vol. 16, Suppl. 7; 1987)
Gyromitrin [16568-02-8] (Vol. 31, Suppl. 7; 1987)
Haematite [1317-60-8] (Vol. 1, Suppl. 7; 1987)
HC Blue No. 2 [33229-34-4] (Vol. 57; 1993)
HC Red No. 3 [2871-01-4] (Vol. 57; 1993)
HC Yellow No. 4 [59820-43-8] (Vol. 57; 1993)
Hepatitis D virus (Vol. 59; 1994)
Hexachlorobutadiene [87-68-3] (Vol. 20, Suppl. 7; 1987)
Hexachloroethane [67-72-1] (Vol. 20, Suppl. 7; 1987)
Hexachlorophene [70-30-4] (Vol. 20, Suppl. 7; 1987)
Human T-cell lymphotropic virus type II (Vol. 67; 1996)
Hycanthone mesylate [23255-93-8] (Vol. 13, Suppl. 7; 1987)
Hydralazine [86-54-4] (Vol. 24, Suppl. 7; 1987)
Hydrochloric acid [7647-01-0] (Vol. 54; 1992)
Hydrochlorothiazide [58-93-5] (Vol. 50; 1990)
Hydrogen peroxide [7722-84-1] (Vol. 36, Suppl. 7; 1987)
Hydroquinone [123-31-9] (Vol. 15, Suppl. 7; 1987)
4-Hydroxyazobenzene [1689-82-3] (Vol. 8, Suppl. 7; 1987)
8-Hydroxyquinoline [148-24-3] (Vol. 13, Suppl. 7; 1987)
Hydroxysenkirkine [26782-43-4] (Vol. 10, Suppl. 7; 1987)
Hypochlorite salts (Vol. 52; 1991)
Iron-dextrin complex [9004-51-7] (Vol. 2, Suppl. 7; 1987)
Iron sorbitol-citric acid complex [1338-16-5] (Vol. 2, Suppl. 7; 1987)
Isatidine [15503-86-3] (Vol. 10, Suppl. 7; 1987)
Isonicotinic acid hydrazide (Isoniazid) [54-85-3] (Vol. 4, Suppl. 7; 1987)
Isophosphamide [3778-73-2] (Vol. 26, Suppl. 7; 1987)
Isopropanol [67-63-0] (Vol. 15, Suppl. 7; 1987)
Isopropyl oils (Vol. 15, Suppl. 7; 1987)
Isosafrole [120-58-1] (Vol. 10, Suppl. 7; 1987)
Jacobine [6870-67-3] (Vol. 10, Suppl. 7; 1987)
Kaempferol [520-18-3] (Vol. 31, Suppl. 7; 1987)
Lauroyl peroxide [105-74-8] (Vol. 36, Suppl. 7; 1987)
Lead, organo [75-74-1], [78-00-2] (Vol. 23, Suppl. 7; 1987)
Light Green SF [5141-20-8] (Vol. 16, Suppl. 7; 1987)
d-Limonene [5989-27-5] (Vol. 56; 1993)
Luteoskyrin [21884-44-6] (Vol. 10, Suppl. 7; 1987)
Malathion [121-75-5] (Vol. 30, Suppl. 7; 1987)
Maleic hydrazide [123-33-1] (Vol. 4, Suppl. 7; 1987)
Malonaldehyde [542-78-9] (Vol. 36, Suppl. 7; 1987)
Maneb [12427-38-2] (Vol. 12, Suppl. 7; 1987)
Mannomustine dihydrochloride [551-74-6] (Vol. 9, Suppl. 7; 1987)
Medphalan [13045-94-8] (Vol. 9, Suppl. 7; 1987)
Melamine [108-78-1] (Vol. 39, Suppl. 7; 1987)
6-Mercaptopurine [50-44-2] (Vol. 26, Suppl. 7; 1987)
Mercury [7439-97-6] and inorganic mercury compounds (Vol. 58; 1993)
Metabisulfites (Vol. 54; 1992)
Methotrexate [59-05-2] (Vol. 26, Suppl. 7; 1987)
Methoxychlor [72-43-5] (Vol. 20, Suppl. 7; 1987)
Methyl acrylate [96-33-3] (Vol. 39, Suppl. 7; 1987)
5-Methylangelicin [73459-03-7] plus ultraviolet A radiation (Suppl. 7; 1987)
Methyl bromide [74-83-9] (Vol. 41, Suppl. 7; 1987)
Methyl carbamate [598-55-0] (Vol. 12, Suppl. 7; 1987)
Methyl chloride [74-87-3] (Vol. 41, Suppl. 7; 1987)
1-Methylchrysene [3351-28-8] (Vol. 32, Suppl. 7; 1987)
2-Methylchrysene [3351-32-4] (Vol. 32, Suppl. 7; 1987)
3-Methylchrysene [3351-31-3] (Vol. 32, Suppl. 7; 1987)
4-Methylchrysene [3351-30-2] (Vol. 32, Suppl. 7; 1987)
6-Methylchrysene [1705-85-7] (Vol. 32, Suppl. 7; 1987)
N-Methyl-N,4-dinitrosoaniline [99-80-9] (Vol. 1, Suppl. 7; 1987)
4,4'-Methylene bis(N,N-dimethyl)benzenamine [101-61-1] (Vol. 27, Suppl. 7;
1987)
4,4'-Methylenediphenyl diisocyanate [101-68-8] (Vol. 19, Suppl. 7; 1987)
2-Methylfluoranthene [33543-31-6] (Vol. 32, Suppl. 7; 1987)
3-Methylfluoranthene [1706-01-0] (Vol. 32, Suppl. 7; 1987)
Methylglyoxal [78-98-8] (Vol. 51; 1991)
Methyl iodide [74-88-4] (Vol. 41, Suppl. 7; 1987)
Methyl methacrylate [80-62-6] (Vol. 60; 1994)
N-Methylolacrylamide [90456-67-0] (Vol. 60; 1994)
Methyl parathion [298-00-0] (Vol. 30, Suppl. 7; 1987)
1-Methylphenanthrene [832-69-9] (Vol. 32, Suppl. 7; 1987)
7-Methylpyrido[3,4-c]psoralen [85878-62-2] (Vol. 40, Suppl. 7; 1987)
Methyl red [493-52-7] (Vol. 8, Suppl. 7; 1987)
Methyl selenac [144-34-3] (Vol. 12, Suppl. 7; 1987)
Modacrylic fibres (Vol. 19, Suppl. 7; 1987)
Monuron [150-68-5] (Vol. 53; 1991)
Morpholine [110-91-8] (Vol. 47; 1989)
Musk ambrette [83-66-9] (Vol. 65; 1996)
Musk xylene [81-15-2] (Vol. 65; 1996)
1,5-Naphthalenediamine [2243-62-1] (Vol. 27, Suppl. 7; 1987)
1,5-Naphthalene diisocyanate [3173-72-6] (Vol. 19, Suppl. 7; 1987)
1-Naphthylamine [134-32-7] (Vol. 4, Suppl. 7; 1987)
1-Naphthylthiourea (ANTU) [86-88-4] (Vol. 30, Suppl. 7; 1987)
Nithiazide [139-94-6] (Vol. 31, Suppl. 7; 1987)
5-Nitro-ortho-anisidine [99-59-2] (Vol. 27, Suppl. 7; 1987)
9-Nitroanthracene [602-60-8] (Vol. 33, Suppl. 7; 1987)
7-Nitrobenz[a]anthracene [20268-51-3] (Vol. 46; 1989)
6-Nitrobenzo[a]pyrene [63041-90-7] (Vol. 46; 1989)
4-Nitrobiphenyl [92-93-3] (Vol. 4, Suppl. 7; 1987)
3-Nitrofluoranthene [892-21-7] (Vol. 33, Suppl. 7; 1987)
Nitrofural (Nitrofurazone) [59-87-0] (Vol. 50; 1990)
Nitrofurantoin [67-20-9] (Vol. 50; 1990)
1-Nitronaphthalene [86-57-7] (Vol. 46; 1989)
2-Nitronaphthalene [581-89-5] (Vol. 46; 1989)
3-Nitroperylene [20589-63-3] (Vol. 46; 1989)
2-Nitropyrene [789-07-1] (Vol. 46; 1989)
N'-Nitrosoanabasine [37620-20-5] (Vol. 37, Suppl. 7; 1987)
N'-Nitrosoanatabine [71267-22-6] (Vol. 37, Suppl. 7; 1987)
N-Nitrosodiphenylamine [86-30-6] (Vol. 27, Suppl. 7; 1987)
para-Nitrosodiphenylamine [156-10-5] (Vol. 27, Suppl. 7; 1987)
N-Nitrosofolic acid [29291-35-8] (Vol. 17, Suppl. 7; 1987)
N-Nitrosoguvacine [55557-01-2] (Vol. 37, Suppl. 7; 1987)
N-Nitrosoguvacoline [55557-02-3] (Vol. 37, Suppl. 7; 1987)
N-Nitrosohydroxyproline [30310-80-6] (Vol. 17, Suppl. 7; 1987)
3-(N-Nitrosomethylamino)propionaldehyde [85502-23-4] (Vol. 37, Suppl. 7;
1987)
4-(N-Nitrosomethylamino)-4-(3-pyridyl)-1-butanal (NNA) [64091-90-3] (Vol.
37, Suppl. 7; 1987)
N-Nitrosoproline [7519-36-0] (Vol. 17, Suppl. 7; 1987)
Nitrotoluenes [88-72-2; 99-08-1; 99-99-0] (Vol. 65; 1996)
5-Nitro-ortho-toluidine [99-55-8] (Vol. 48; 1990)
Nitrovin [804-36-4] (Vol. 31, Suppl. 7; 1987)
Nylon 6 [25038-54-4] (Vol. 19, Suppl. 7; 1987)
Oestradiol mustard [22966-79-6] (Vol. 9, Suppl. 7; 1987)
Oestrogen-progestin replacement therapy (Suppl. 7; 1987)
Opisthorchis felineus (infection with) (Vol. 61; 1994)
Orange I [523-44-4] (Vol. 8, Suppl. 7; 1987)
Orange G [1936-15-8] (Vol. 8, Suppl. 7; 1987)
Oxyphenbutazone [129-20-4] (Vol. 13, Suppl. 7; 1987)
Palygorskite (attapulgite) [12174-11-7] (short fibres, < 5 micrometers)
(Vol. 68; 1997)
Paracetamol (Acetaminophen) [103-90-2] (Vol. 50; 1990)
Parasorbic acid [10048-32-5] (Vol. 10, Suppl. 7; 1987)
Parathion [56-38-2] (Vol. 30, Suppl. 7; 1987)
Patulin [149-29-1] (Vol. 40, Suppl. 7; 1987)
Penicillic acid [90-65-3] (Vol. 10, Suppl. 7; 1987)
Pentachloroethane [76-01-7] (Vol. 41, Suppl. 7; 1987)
Permethrin [52645-53-1] (Vol. 53; 1991)
Perylene [198-55-0] (Vol. 32, Suppl. 7; 1987)
Petasitenine [60102-37-6] (Vol. 31, Suppl. 7; 1987)
Phenanthrene [85-01-8] (Vol. 32, Suppl. 7; 1987)
Phenelzine sulfate [156-51-4] (Vol. 24, Suppl. 7; 1987)
Phenicarbazide [103-03-7] (Vol. 12, Suppl. 7; 1987)
Phenol [108-95-2] (Vol. 47; 1989)
Phenylbutazone [50-33-9] (Vol. 13, Suppl. 7; 1987)
meta-Phenylenediamine [108-45-2] (Vol. 16, Suppl. 7; 1987)
para-Phenylenediamine [106-50-3] (Vol. 16, Suppl. 7; 1987)
N-Phenyl-2-naphthylamine [135-88-6] (Vol. 16, Suppl. 7; 1987)
ortho-Phenylphenol [90-43-7] (Vol. 30, Suppl. 7; 1987)
Picloram [1918-02-1] (Vol. 53; 1991)
Piperonyl butoxide [51-03-6] (Vol. 30, Suppl. 7; 1987)
Polyacrylic acid [9003-01-4] (Vol. 19, Suppl. 7; 1987)
Polychlorinated dibenzo-para-dioxins (other than
2,3,7,8-tetrachlorodibenzo-para-dioxin) (Vol. 69; 1997)
Polychlorinated dibenzofurans (Vol. 69; 1997)
Polychloroprene [9010-98-4] (Vol. 19, Suppl. 7; 1987)
Polyethylene [9002-88-4] (Vol. 19, Suppl. 7; 1987)
Polymethylene polyphenyl isocyanate [9016-87-9] (Vol. 19, Suppl. 7; 1987)
Polymethyl methacrylate [9011-14-7] (Vol. 19, Suppl. 7; 1987)
Polypropylene [9003-07-0] (Vol. 19, Suppl. 7; 1987)
Polystyrene [9003-53-6] (Vol. 19, Suppl. 7; 1987)
Polytetrafluoroethylene [9002-84-0] (Vol. 19, Suppl. 7; 1987)
Polyurethane foams [9009-54-5] (Vol. 19, Suppl. 7; 1987)
Polyvinyl acetate [9003-20-7] (Vol. 19, Suppl. 7; 1987)
Polyvinyl alcohol [9002-89-5] (Vol. 19, Suppl. 7; 1987)
Polyvinyl chloride [9002-86-2] (Vol. 19, Suppl. 7; 1987)
Polyvinyl pyrrolidone [9003-39-8] (Vol. 19, Suppl. 7; 1987)
Ponceau SX [4548-53-2] (Vol. 8, Suppl. 7; 1987)
Potassium bis(2-hydroxyethyl)dithiocarbamate [23746-34-1] (Vol. 12, Suppl.
7; 1987)
Prazepam [2955-38-6] (Vol. 66; 1996)
Prednimustine [29069-24-7] (Vol. 50; 1990)
Prednisone [53-03-2] (Vol. 26, Suppl. 7; 1987)
Proflavine salts (Vol. 24, Suppl. 7; 1987)
Pronetalol hydrochloride [51-02-5] (Vol. 13, Suppl. 7; 1987)
Propham [122-42-9] (Vol. 12, Suppl. 7; 1987)
n-Propyl carbamate [627-12-3] (Vol. 12, Suppl. 7; 1987)
Propylene [115-07-1] (Vol. 60; 1994)
Ptaquiloside [87625-62-5] (Vol. 40, Suppl. 7; 1987)
Pyrene [129-00-0] (Vol. 32, Suppl. 7; 1987)
Pyrido[3,4-c]psoralen [85878-62-2] (Vol. 40, Suppl. 7; 1987)
Pyrimethamine [58-14-0] (Vol. 13, Suppl. 7; 1987)
Quercetin [117-39-5] (Vol. 31, Suppl. 7; 1987)
para-Quinone [106-51-4] (Vol. 15, Suppl. 7; 1987)
Quintozene (Pentachloronitrobenzene) [82-68-8] (Vol. 5, Suppl. 7; 1987)
Reserpine [50-55-5] (Vol. 24, Suppl. 7; 1987)
Resorcinol [108-46-3] (Vol. 15, Suppl. 7; 1987)
Retrorsine [480-54-6] (Vol. 10, Suppl. 7; 1987)
Rhodamine B [81-88-9] (Vol. 16, Suppl. 7; 1987)
Rhodamine 6G [989-38-8] (Vol. 16, Suppl. 7; 1987)
Riddelliine [23246-96-0] (Vol. 10, Suppl. 7; 1987)
Rifampicin [13292-46-1] (Vol. 24, Suppl. 7; 1987)
Ripazepam [26308-28-1] (Vol. 66; 1996)
Rugulosin [23537-16-8] (Vol. 40, Suppl. 7; 1987)
Saccharated iron oxide [8047-67-4] (Vol. 2, Suppl. 7; 1987)
Scarlet Red [85-83-6] (Vol. 8, Suppl. 7; 1987)
Schistosoma mansoni (infection with) (Vol. 61; 1994)
Selenium [7782-49-2] and selenium compounds (Vol. 9, Suppl. 7; 1987)
Semicarbazide hydrochloride [563-41-7] (Vol. 12, Suppl. 7; 1987)
Seneciphylline [480-81-9] (Vol. 10, Suppl. 7; 1987)
Senkirkine [2318-18-5] (Vol. 31, Suppl. 7; 1987)
Sepiolite [15501-74-3] (Vol. 68; 1997)
Shikimic acid [138-59-0] (Vol. 40, Suppl. 7; 1987)
Silica [7631-86-9], amorphous (Vol. 68; 1997)
Simazine [122-34-9] (Vol. 53; 1991)
Sodium chlorite [7758-19-2] (Vol. 52; 1991)
Sodium diethyldithiocarbamate [148-18-5] (Vol. 12, Suppl. 7; 1987)
Spironolactone [52-01-7] (Vol. 24, Suppl. 7; 1987)
Styrene-acrylonitrile copolymers [9003-54-7] (Vol. 19, Suppl. 7; 1987)
Styrene-butadiene copolymers [9003-55-8] (Vol. 19, Suppl. 7; 1987)
Succinic anhydride [108-30-5] (Vol. 15, Suppl. 7; 1987)
Sudan I [842-07-9] (Vol. 8, Suppl. 7; 1987)
Sudan II [3118-97-6] (Vol. 8, Suppl. 7; 1987)
Sudan III [85-86-9] (Vol. 8, Suppl. 7; 1987)
Sudan Brown RR [6416-57-5] (Vol. 8, Suppl. 7; 1987)
Sudan Red 7B [6368-72-5] (Vol. 8, Suppl. 7; 1987)
Sulfafurazole (Sulfisoxazole) [127-69-5] (Vol. 24, Suppl. 7; 1987)
Sulfamethoxazole [723-46-6] (Vol. 24, Suppl. 7; 1987)
Sulfites (Vol. 54; 1992)
Sulfur dioxide [7446-09-5] (Vol. 54; 1992)
Sunset Yellow FCF [2783-94-0] (Vol. 8, Suppl. 7; 1987)
Symphytine [22571-95-5] (Vol. 31, Suppl. 7; 1987)
Talc [14807-96-6], not containing asbestiform fibres (Vol. 42, Suppl. 7;
1987)
Tannic acid [1401-55-4] and tannins (Vol. 10, Suppl. 7; 1987)
Temazepam [846-50-4] (Vol. 66; 1996)
2,2',5,5'-Tetrachlorobenzidine [15721-02-5] (Vol. 27, Suppl. 7; 1987)
1,1,1,2-Tetrachloroethane [630-20-6] (Vol. 41, Suppl. 7; 1987)
1,1,2,2-Tetrachloroethane [79-34-5] (Vol. 20, Suppl. 7; 1987)
Tetrachlorvinphos [22248-79-9] (Vol. 30, Suppl. 7; 1987)
Tetrafluoroethylene [116-14-3] (Vol. 19, Suppl. 7; 1987)
Tetrakis(hydroxymethyl)phosphonium salts (Vol. 48; 1990)
Theobromine [83-67-0] (Vol. 51; 1991)
Theophylline [58-55-9] (Vol. 51; 1991)
Thiouracil [141-90-2] (Vol. 7, Suppl. 7; 1987)
Thiram [137-26-8] (Vol. 53; 1991)
Titanium dioxide [13463-67-7] (Vol. 47; 1989)
Toluene [108-88-3] (Vol. 47; 1989)
Toremifene [89778-26-7] (Vol. 66; 1996)
Toxins derived from Fusarium graminearum, F. culmorum and F. crookwellense
(Vol. 56; 1993)
Toxins derived from Fusarium sporotrichioides (Vol. 56; 1993)
Trichlorfon [52-68-6] (Vol. 30, Suppl. 7; 1987)
Trichloroacetic acid [76-03-9] (Vol. 63; 1995)
Trichloroacetonitrile [545-06-2] (Vol. 52; 1991)
1,1,1-Trichloroethane [71-55-6] (Vol. 20, Suppl. 7; 1987)
1,1,2-Trichloroethane [79-00-5] (Vol. 52; 1991)
Triethylene glycol diglycidyl ether [1954-28-5] (Vol. 11, Suppl. 7; 1987)
Trifluralin [1582-09-8] (Vol. 53; 1991)
4,4',6-Trimethylangelicin [90370-29-9] plus ultraviolet A radiation (Suppl.
7; 1987)
2,4,5-Trimethylaniline [137-17-7] (Vol. 27, Suppl. 7; 1987)
2,4,6-Trimethylaniline [88-05-1] (Vol. 27, Suppl. 7; 1987)
4,5',8-Trimethylpsoralen [3902-71-4] (Vol. 40, Suppl. 7; 1987)
2,4,6-Trinitrotoluene [118-96-7] (Vol. 65; 1996)
Triphenylene [217-59-4] (Vol. 32, Suppl. 7; 1987)
Tris(aziridinyl)-para-benzoquinone (Triaziquone) [68-76-8] (Vol. 9, Suppl.
7; 1987)
Tris(1-aziridinyl)phosphine oxide [545-55-1] (Vol. 9, Suppl. 7; 1987)
2,4,6-Tris(1-aziridinyl)-s-triazine [51-18-3] (Vol. 9, Suppl. 7; 1987)
Tris(2-chloroethyl) phosphate [115-96-8] (Vol. 48; 1990)
1,2,3-Tris(chloromethoxy)propane [38571-73-2] (Vol. 15, Suppl. 7; 1987)
Tris(2-methyl-1-aziridinyl)phosphine oxide [57-39-6] (Vol. 9, Suppl. 7;
1987)
Vat Yellow 4 [128-66-5] (Vol. 48; 1990)
Vinblastine sulfate [143-67-9] (Vol. 26, Suppl. 7; 1987)
Vincristine sulfate [2068-78-2] (Vol. 26, Suppl. 7; 1987)
Vinyl chloride-vinyl acetate copolymers [9003-22-9] (Vol. 19, Suppl. 7;
1987)
Vinylidene chloride [75-35-4] (Vol. 39, Suppl. 7; 1987)
Vinylidene chloride-vinyl chloride copolymers [9011-06-7] (Vol. 19, Suppl.
7; 1987)
Vinylidene fluoride [75-38-7] (Vol. 39, Suppl. 7; 1987)
N-Vinyl-2-pyrrolidone [88-12-0] (Vol. 19, Suppl. 7; 1987)
Vinyl toluene [25013-15-4] (Vol. 60; 1994)
Wollastonite [13983-17-0] (Vol. 68; 1997)
Xylene [1330-20-7] (Vol. 47; 1989)
2,4-Xylidine [95-68-1] (Vol. 16, Suppl. 7; 1987)
2,5-Xylidine [95-78-3] (Vol. 16, Suppl. 7; 1987)
Yellow AB [85-84-7] (Vol. 8, Suppl. 7; 1987)
Yellow OB [131-79-3] (Vol. 8, Suppl. 7; 1987)
Zectran [315-18-4] (Vol. 12, Suppl. 7; 1987)
Zeolites [1318-02-1] other than erionite (clinoptilolite, phillipsite,
mordenite, non-fibrous Japanese zeolite, synthetic zeolites) (Vol. 68; 1997)
Zineb [12122-67-7] (Vol. 12, Suppl. 7; 1987)
Ziram [137-30-4] (Vol. 53; 1991)
Mixtures
Betel quid, without tobacco (Vol. 37, Suppl. 7; 1987)
Bitumens [8052-42-4], steam-refined, cracking-residue and air-refined (Vol.
35, Suppl. 7; 1987)
Crude oil [8002-05-9] (Vol. 45; 1989)
Diesel fuels, distillate (light) (Vol. 45; 1989)
Fuel oils, distillate (light) (Vol. 45; 1989)
Jet fuel (Vol. 45; 1989)
Mate (Vol. 51; 1991)
Mineral oils, highly-refined (Vol. 33, Suppl. 7; 1987)
Petroleum solvents (Vol. 47; 1989)
Printing inks (Vol. 65; 1996)
Tea (Vol. 51; 1991)
Terpene polychlorinates (Strobane.) [8001-50-1] (Vol. 5, Suppl. 7; 1987)
Exposure circumstances
Flat-glass and specialty glass (manufacture of) (Vol. 58; 1993)
Hair colouring products (personal use of) (Vol. 57; 1993)
Leather goods manufacture (Vol. 25, Suppl. 7; 1987)
Leather tanning and processing (Vol. 25, Suppl. 7; 1987)
Lumber and sawmill industries (including logging) (Vol. 25, Suppl. 7; 1987)
Paint manufacture (occupational exposure in) (Vol. 47; 1989)
Pulp and paper manufacture (Vol. 25, Suppl. 7; 1987)
----------------------------------------------------------------------------
Group 4: Probably not carcinogenic to humans (1)
Caprolactam [105-60-2] (Vol. 39, Suppl. 7; 1987)
----------------------------------------------------------------------------
Return to menu
Complete list of Monographs and Supplements
First published: 12 November 1995
Last updated: 28 February 1997
|
